| Cash Flow | 2025-06-27 | 2025-03-28 | 2024-12-27 | 2024-06-28 |
|---|---|---|---|---|
| Share-based compensation expense | 44,721 | 30,296 | 14,848 | 46,895 |
| Reduction of contingent consideration liability (see note 14) | - | - | - | 0 |
| Net income | 239,628 | 167,676 | 105,703 | - |
| Other operating activities | 56,965 | 37,693 | 20,968 | 106,027 |
| Prepayments and other current assets | 33,163 | 47,718 | 10,691 | 3,548 |
| Inventories | -1,361 | 15,858 | -13,938 | -27,632 |
| Payments made to clients on contracts | 99,453 | 86,850 | 61,032 | 108,262 |
| Accrued expenses | -344,116 | -257,335 | -383,370 | -353,730 |
| Receivables | 207,828 | 151,736 | 159,800 | 236,390 |
| Accounts payable | -275,591 | -251,693 | -261,503 | -224,211 |
| Net income from continuing operations | - | - | - | 139,640 |
| Gain on sale of equity investments, net | - | - | - | 0 |
| Depreciation and amortization | 352,085 | 230,263 | 113,204 | 322,794 |
| Deferred income taxes | -263 | 2,931 | 9,456 | -11,948 |
| Asset write-downs | - | - | - | 0 |
| Increase in contingent consideration liability (see note 11) | 11,127 | 11,127 | 11,127 | - |
| Net cash used in operating activities of continuing operations | - | - | - | -295,101 |
| Net cash used in operating activities | -254,527 | -331,204 | -587,152 | - |
| Disposals of property and equipment | 4,325 | 3,175 | 2,073 | 17,228 |
| Proceeds from sale of equity investments | - | - | - | 0 |
| Proceeds from marketable securities | 0 | 0 | - | 71,215 |
| Purchases of property and equipment and other | 347,039 | 235,661 | 119,861 | 288,140 |
| Purchases of marketable securities | 0 | 0 | - | 71,215 |
| Acquisition of certain businesses, net of cash acquired | 263,043 | 247,800 | 111,366 | 106,334 |
| Other investing activities | 8,421 | 2,184 | 1,685 | 2,158 |
| Net cash (used in) provided by investing activities of continuing operations | - | - | - | -379,404 |
| Net cash used in investing activities | -614,178 | -482,470 | -230,839 | - |
| Payments of long-term borrowings | 1,851,545 | 1,412,732 | 10,781 | 1,591,906 |
| Net change in funding under the receivables facility | 570,000 | 586,000 | 525,000 | 599,000 |
| Other financing activities | -74,164 | -61,321 | -36,431 | -56,006 |
| Proceeds from long-term borrowings | 2,222,037 | 2,103,204 | 180,793 | 298,329 |
| Proceeds from issuance of common stock | 36,427 | 16,379 | 11,977 | 24,872 |
| Payments of dividends | 83,222 | 55,683 | 27,860 | 74,853 |
| Net cash (used in) provided by financing activities of continuing operations | - | - | - | -800,564 |
| Net cash provided by operating activities | - | - | - | 0 |
| Net cash used in investing activities | - | - | - | 0 |
| Net cash used in financing activities | - | - | - | 0 |
| Repurchase of common stock | 140,156 | 109,283 | - | - |
| Net cash provided by discontinued operations | - | - | - | 0 |
| Net cash provided by (used in) financing activities | 679,377 | 1,066,564 | 642,698 | - |
| Effect of foreign exchange rates on cash and cash equivalents and restricted cash | 14,419 | -11,497 | -18,960 | -1,769 |
| Decrease in cash and cash equivalents and restricted cash | -174,909 | 241,393 | -194,253 | -1,476,838 |
Aramark (ARMK)
Aramark (ARMK)